Selected to Present at Cavendish Global Health Impact Forum

 

Forum uniquely brings together leading family offices, their foundations and sovereign wealth fund representatives seeking impact investment, grant-giving, and philanthropy opportunities within health and life sciences

 

Branford, CT, — Tangen Biosciences, a molecular diagnostic device development company, announced today it has been selected to present at the Cavendish Global Health Impact Forum taking place February 15th to February 18th at the Breakers in Palm Beach, Florida.  The purpose of the Forum is to help family offices and foundations develop and implement their individual pro-social impact investing, grant-giving, and philanthropy programs within health and the life sciences.  To accomplish this mission, the Forum showcases presentations and panel discussions by leading family offices, accomplished foundations, research institutions, and private-sector companies engaged in developing innovations with the potential for transformational impact on disease prevention, diagnosis and treatment.  A unique gathering of family offices, Cavendish Impact Forums are hosted by leading institutions around the world and take place three times each year.

 

Michael Moffat, Cavendish co-founder and Chief Executive Officer explains, “The theme of our Palm Beach Forum is a ‘Celebration of Philanthropy, Impact Investing and Innovation that is changing the World.’  With the help of our expert advisors, we conduct a global search of research institutions and private-sector companies in order to identify organizations that meet the required standard of excellence.  The quality and originality of Tangen Biosciences approach to mobile molecular diagnostic instrumentation systems, and their pulmonary Tuberculosis assay, positions them to make a major contribution to the diagnosis, treatment, and eventual eradication of this terrible and currently widespread disease.”

 

“We are honored to be selected to present at this unique event, and it is further recognition of our innovative approach to the diagnosis of active Tuberculosis, afflicting essentially all populations around the world today,” said John Nobile, CEO. “We welcome the chance to interact with many of world’s most accomplished scientists, thought-leaders and generous philanthropic individuals and families who are all dedicated to the common cause of improving the health and lives of people around the world.”

 

Cavendish Global consists of over 200 leading family offices and foundations from around the world with combined assets of over $260 billion who share a passion for pro-social endeavors within health and the life sciences. The Cavendish Global Health Impact Forum provides family offices with a discrete, peer-to-peer knowledge expansion and relationship building environment, combined with the information and educational resources required by foundations actively seeking to accelerate technological innovation and health access through sustainable philanthropy, grant-making and impact investing.  The Forum is also an opportunity for family offices to champion and share information on projects and organizations, which they are passionate about with other family offices from around the world.